{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:49:15Z","timestamp":1790704155425,"version":"4.1.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2000,3]]},"DOI":"10.1067\/mai.2000.104550","type":"journal-article","created":{"date-parts":[[2003,11,13]],"date-time":"2003-11-13T12:16:51Z","timestamp":1068725811000},"page":"489-494","source":"Crossref","is-referenced-by-count":57,"title":["Onset of action of intranasal budesonide (Rhinocort Aqua) in seasonal allergic rhinitis studied in a controlled exposure model"],"prefix":"10.1067","volume":"105","author":[{"given":"James H.","family":"Day","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen P.","family":"Briscoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Rafeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne K.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Pettersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"\u00c5kerlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1067\/mai.2000.104550_bib1","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/0091-6749(90)90091-H","article-title":"A double-blind, single-dose, crossover comparison of cetirizine, terfenadine, loratadine, astemizole and chlorpheniramine versus placebo: suppressive effects on histamine-induced wheals and flares during 24 hours in normal subjects","volume":"86","author":"Simons","year":"1990","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2000.104550_bib2","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0091-6749(96)70257-9","article-title":"A randomized, double-blind, placebo-controlled, controlled antigen delivery study of the onset of action of aerosolized triamcinolone acetonide nasal spray in subjects with ragweed-induced allergic rhinitis","volume":"97","author":"Day","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2000.104550_bib3","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2500\/105065897781446658","article-title":"A comparison of aqueous suspensions of budesonide nasal spray (128 \u03bcg and 256 \u03bcg once daily) and fluticasone propionate nasal spray (200 \u03bcg once daily) in the treatment of adult patients with seasonal allergic rhinitis","volume":"11","author":"Stern","year":"1997","journal-title":"Am J Rhinol"},{"key":"10.1067\/mai.2000.104550_bib4","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0091-6749(98)70326-4","article-title":"Comparison of the efficacy of budesonide and fluticasone propionate aqueous nasal spray for once daily treatment of perennial allergic rhinitis","volume":"102","author":"Day","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2000.104550_bib5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1081-1206(10)62616-6","article-title":"Environmental exposure unit: a system to test anti-allergic treatment","volume":"83","author":"Day","year":"1999","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1067\/mai.2000.104550_bib6","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0091-6749(98)70172-1","article-title":"Cetirizine, loratadine or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit","volume":"101","author":"Day","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2000.104550_bib7","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1081-1206(10)63104-3","article-title":"Onset of action and efficacy of terfenadine, astemizole, cetirizine, and loratadine for the relief of symptoms of allergic rhinitis","volume":"79","author":"Day","year":"1997","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1067\/mai.2000.104550_bib8","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1081-1206(10)63062-1","article-title":"Onset of action, efficacy, and safety of a single dose of fexofenadine hydrochloride for ragweed allergy using an environmental exposure unit","volume":"79","author":"Day","year":"1997","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1067\/mai.2000.104550_bib9","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S1081-1206(10)63483-7","article-title":"Efficacy of immunotherapy to ragweed antigen tested by controlled antigen exposure","volume":"77","author":"Donovan","year":"1996","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1067\/mai.2000.104550_bib10","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0021-8707(68)90053-1","article-title":"Quantitative intranasal pollen challenge. II. Effect of daily pollen challenge, environmental pollen exposure, and placebo challenge on the nasal membrane","volume":"41","author":"Connell","year":"1968","journal-title":"J Allergy"},{"key":"10.1067\/mai.2000.104550_bib11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0021-8707(69)90018-5","article-title":"Quantitative intranasal pollen challenges. III. The priming effect in allergic rhinitis","volume":"43","author":"Connell","year":"1969","journal-title":"J Allergy"},{"key":"10.1067\/mai.2000.104550_bib12","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1365-2273.1989.tb00416.x","article-title":"Intranasally administered budesonide, a glucocorticoid, does not exert its clinical effect through vasoconstriction","volume":"14","author":"Lindqvist","year":"1989","journal-title":"Clin Otolaryngol"},{"key":"10.1067\/mai.2000.104550_bib13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000411423","article-title":"Time-dependent inhibition of bradykinin- and histamine induced increase in microvascular permeability by local glucocorticoid treatment","volume":"19","author":"Svensj\u00f6","year":"1985","journal-title":"Prog Respir Res"},{"key":"10.1067\/mai.2000.104550_bib14","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1056\/NEJM199704103361506","article-title":"Nuclear factor kappa B a pivotal transcription factor in chronic inflammatory diseases","volume":"336","author":"Barnes","year":"1997","journal-title":"N Engl J Med"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674900705112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674900705112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,17]],"date-time":"2019-02-17T04:54:53Z","timestamp":1550379293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674900705112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,3]]}},"alternative-id":["S0091674900705112"],"URL":"https:\/\/doi.org\/10.1067\/mai.2000.104550","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2000,3]]}}}